Parker Institute for Cancer Immunotherapy

OrganisationROR

Trials

  • NCT05478837

    Collaborator, Phase 1, Terminated, 4 people, 28 Jul 2022

  • NCT04007029

    Collaborator, Phase 1, Active, not recruiting, 24 people, 5 Jul 2019

Funded papers

Sources: api.crossref.org

Named in competing interests

Sources: pubmed.ncbi.nlm.nih.gov